In this study, we found that APX3330 significantly decreases PAI-1, MCP-1, MMP9 and RAGE levels in the ischemic brain which may contribute to APX3330 induced neuroprotective and neurorestorative effects in T1DM stroke rats. The gene discussed is MMP9; the disease is type 1 diabetes mellitus.